BioSpace News Archive

Pharm Country

Experiments in Infant Mice Suggest New Way to Prevent Spread of Flu in People

Scientists have long known that some viruses and bacteria begin infections by latching first onto sugar molecules on the surfaces of cells lining the sinuses and throat of mammals, including humans.

January 11, 2024
·
3 min read
Pharm Country

International Association for the Study of Lung Cancer (IASLC) and Lung Cancer Research Foundation (LCRF) Announce Request for Proposals

The Lung Cancer Research Foundation announced that, in partnership with the International Association for the Study of Lung Cancer, submissions are being accepted for the $2.5 million, four-year award, titled IASLC-LCRF Team Science Research Grant on Advancing Therapies Towards Curing Oncogenic-Driven Lung Cancers.

January 11, 2024
·
3 min read
BioMidwest

Archimedes Announces Biosimilars First™, an Industry Leading Program to Drive Biosimilar Adoption in 2024

Archimedes, a recognized leader in specialty drug management solutions, announced BiosimilarsFirst™, a program, which excludes Humira from formulary in favor of low cost, low WAC biosimilars.

January 11, 2024
·
2 min read
Pharm Country

Lung Cancer Research Foundation Announces 2024 Requests for Proposals

The Lung Cancer Research Foundation announced that its 2024 funding mechanisms are now open for submission.

January 11, 2024
·
4 min read
Genetown

LeMaitre to Present at the 26th Annual Needham Growth Conference

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 26th Annual Needham Growth Conference on Friday, January 19, 2024, at 11:00 AM ET.

January 11, 2024
·
1 min read
Genetown

Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Dyne Therapeutics, Inc. announced the closing of its previously announced underwritten public offering of 19,722,500 shares of its common stock at a public offering price of $17.50 per share, which includes 2,572,500 shares issued upon the exercise in full by the underwriters of their option to purchase additional shares of common stock in the offering.

January 11, 2024
·
3 min read
Genetown

Azenta to Host Investor Day on March 14, 2024

Azenta, Inc. announced that it will host an Investor Day on Thursday, March 14, 2024 in New York City.

January 11, 2024
·
1 min read
CrossLink Life Sciences and Heron Therapeutics Partner to Boost ZYNRELEF® Promotion for Post-Operative Pain

Life Sciences, a leading medical device distributor and sales organization, is proud to announce a groundbreaking five-year partnership with Heron Therapeutics, Inc

January 11, 2024
·
1 min read
Drug Development

Dermavant Announces Positive Data from the ADORING Phase 3 Development Program in Atopic Dermatitis with VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as 2 Years Old

Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced new positive efficacy and safety data from analyses of the company’s ADORING Phase 3 development program in atopic dermatitis.

January 11, 2024
·
10 min read
Business

ELIQUENT Life Sciences Announces Steve Purtell as Chief Financial Officer

ELIQUENT Life Sciences today announced the appointment of Steve Purtell as its new chief financial officer (CFO).

January 11, 2024
·
3 min read